Kevin Burton, Ph.D.

Vice President of Research Services

kburton@southernresearch.org

Burton has an extensive background in pharmaceutical research and product development. After earning a doctorate in pharmaceutical sciences from the University of Kentucky, he spent more than 25 years developing novel products in the pharmaceutical and medical device industries. He built a career leading early discovery through late-phase clinical development, holding key leadership positions at Purdue Pharma, DURECT, Nektar Therapeutics, Brookwood Pharmaceuticals, SurModics and Evonik. At Southern Research, Burton oversees the Research Services division, which is tasked with preclinical development and clinical trial support. He attributes much of his career success over the past 20 years to Southern Research and believes in the critical role the organization plays in translating healthcare research into societal impact, jobs and regional opportunity.

Related Articles

Southern Research breaks ground on new biotech center and campus renovations

Southern Research breaks ground on new biotech center and campus renovations

May 16, 2022 | Southern Research

Birmingham, Ala. – Southern Research today broke ground on a flagship biotech center that will anchor the development of 200,000 square feet of new or renovated wet lab space for life sciences. The new facility, located on the corner of R...
Read More
Southern Research announces new key additions to staff, leadership team

Southern Research announces new key additions to staff, leadership team

January 18, 2022 | Southern Research

Southern Research today announced key additions to its staff and leadership team. Brantley Fry has joined the organization as its new vice president of People and Community. Fry served as state director for former U.S. Sen. Doug Jones and most recently has worked as chief of staff and general ...
Read More
Southern Research and Tonix Pharmaceuticals Reports Positive COVID-19 Vaccine Efficacy Results

Southern Research and Tonix Pharmaceuticals Reports Positive COVID-19 Vaccine Efficacy Results

March 25, 2021 | Southern Research

Vaccine Candidate TNX-1800 Protected Both Upper and Lower Airways After Challenge with SARS-CoV-2, Suggesting an Ability to Block Forward Transmission   TNX-1800 is Based on a Proprietary Vaccine Platform Designed to Stimulate Long Term T cell...
Read More